Building strategic partnerships to advance clinical excellence - our recent collaboration with Sharehereon Health has opened doors to high-quality refractory cancer care at Parkway Shanghai Hospital.
On 1 November, Parkway Shanghai Hospital partnered Professor Ding Gang, Founder of Sharehereon Health, to launch the Parkway Shanghai Hospital Oncology Center and Parkway International Refractory Oncology Consultation Center. This strategic collaboration unifies the expertise and resources of both healthcare organisations to deliver better oncology diagnosis and treatment for cancer patients.
“This strategic partnership is a harbinger of more great things to come. Refractory cancer, which is the cancer resistant to standard treatment, is a high potential segment in the private healthcare space and there’s great promise in it cementing our domain expertise in oncology,” shared Dr Prem Kumar Nair, Group CEO of IHH Healthcare, during his opening address.
Buoyed by this new development, IHH China will continue to innovate clinical practices, foster multidisciplinary cooperation and prioritise holistic patient care, to bring hope and improved outcomes to more cancer patients in Shanghai.
Related Stories
Everyday Fortis Heroes: Going Beyond the Call of Duty
At Fortis Hospitals, compassion and courage do not stop at the hospital doors. Time and again, our dedicated medical professionals rise to the occasion - even in the most unexpected places - to save lives and uphold the spirit of care that defines who we are.
Transformation Takes Centerstage at the Parkway Laboratories Staff Town Hall
Transformation was the heartbeat of the day at Parkway Laboratories' 2025 staff town hall on 11 April 2025.
Acibadem Ataşehir Hospital Helps Guinean Patient Walk Again
Thanks to expert care by the Acibadem team, 57-year-old Diané Sarangbe from Guinea is walking again - pain-free - for the first time in years.
Baby Who Couldn’t Pass Stool for Two Years Finds Relief Through Scarless Endoscopic Procedure
AI Meets ICU: Gleneagles Hospital Mumbai Shapes the Future of Patient Care at Criticon 3.0
On 23 March 2025, Gleneagles Hospital Mumbai hosted Criticon 3.0, a landmark medical conference that brought together over 500 doctors to explore the transformative role of artificial intelligence (AI) in critical care.
Gleneagles Hospital Chennai Hosts Gleneagles Liver and Transplant Summit 2025
Gleneagles Hospital Chennai launched the two-day Gleneagles Liver and Transplant Summit (GLTS) 2025 at Chennai.
